Suninov 12.5mg Capsules

Manufacturer
NOVUGEN ONCOLOGY SDN. BHD.(MALAYSIA)

Registraction Number
MAL24096070AE

Content:
Suninov 12.5mg Capsules contain the active ingredient sunitinib at a dose of 12.5 mg. Sunitinib is a tyrosine kinase inhibitor used to treat certain types of cancer by inhibiting the activity of proteins involved in the growth and spread of cancer cells.
Indications:

• Gastrointestinal Stromal Tumor (GIST): For patients whose disease has progressed on or who are intolerant to imatinib mesylate.
• Advanced Renal Cell Carcinoma (RCC): For patients with advanced kidney cancer that has spread to other parts of the body.
• Adjuvant Treatment of RCC: For adult patients at high risk of recurrent kidney cancer following nephrectomy.
• Progressive, Well-Differentiated Pancreatic Neuroendocrine Tumors (pNET): For patients with unresectable locally advanced or metastatic disease.

1. Administration: Take orally, as directed by your doctor.
2. Dosage: The usual dose is one capsule once daily with food.
3. Timing: Take it at the same time each day to help you remember.
4. Monitoring: Regular monitoring of blood pressure, heart function, and blood tests is essential to ensure the medication is effective and to manage side effects.